 "Hoping two Covid-19 vaccines would be approved soon, says UK PM Johnson")
UK Prime Minister Boris Johnson said on Monday he hoped that two promising coronavirus vaccine candidates would be approved shortly.
The Medicines and Healthcare Products Regulatory Agency is yet to greenlight the Pfizer-BioNTech and Oxford-AstraZeneca co-labs.
"We're obviously hoping that both the Pfizer-BioNTech vaccine and the Oxford-AstraZeneca vaccine will get approved in the course of the next few days and weeks," he told reporters during a trip to a medical facility.
Asked whether that meant before vaccines would get a go-ahead before Christmas, the prime minister replied "That's the hope."
Johnson stressed that his government could not let the optimist "run away with us." But he added there was every reason to believe that a working vaccine could turn the tide in the struggle against the virus.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app